SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
531TolerRx Initiates Three Clinical Trials in Autoimmune Indications Wednesday Decenigel bates-12/7/2005
530There is so much that can be studied here. I haven't kept a diary, but I am Mike McFarland-12/6/2005
529Love hurts? So does a wounded marriage By Michael Conlon news.yahoo.com CHICAscaram(o)uche-12/6/2005
528ACR: CNTO-148 Demonstrates Efficacy for RA Message 21905092Icebrg-11/21/2005
527ACR Rituxan Shows Durable Response for Refractory RA By Lynne Peterson, SpecialIcebrg-11/21/2005
526Actemra monotherapy significantly slows down damage to joints in patients with eJohn McCarthy-11/17/2005
525Clin Gastroenterol Hepatol. 2005 Nov;3(11):1075-82. Time course and pattern ofscaram(o)uche-11/8/2005
524UCB: Phase III Study Shows CIMZIA is an Effective and Well-Tolerated Treatment fIcebrg-10/18/2005
523Norman Cousins used this cure over 40 years ago. wholehealthmd.comfreelyhovering-9/26/2005
522J Bone Miner Res. 2005 Oct;20(10):1756-65. Epub 2005 Jun 6. Related Articles, Likeokalani'nui-9/23/2005
521Clin Exp Rheumatol. 2005 Sep-Oct;23(5):651-7. Effects of mirthful laughter on scaram(o)uche-9/22/2005
520news.bbc.co.uk Bowel study backs cannabis drugs Patients with inflammatory bscaram(o)uche-8/2/2005
519J Neuroimmunol. 2005 Jul 12; [Epub ahead of print] Cannabinoids and the immunescaram(o)uche-7/29/2005
518Breakthrough In National Diseases: Common Factor Behind Myocardial Infarction, RJohn McCarthy-5/9/2005
517Avidex / CD80 antagonist PI Oxford(UK), Avidex today announced that its first pnigel bates-5/9/2005
516nature.com Nature Reviews Immunology 5, 400-411 (2005) CANNABINOID-BASED DRUGSscaram(o)uche-5/3/2005
515BG-12 Psoriasis Study Meets Primary Endpoint Thursday April 7, 8:00 am ET Oral nigel bates-4/7/2005
514Serono Announces Discontinuation of Onercept in Moderate-to-Severe Psoriasis andscaram(o)uche-4/6/2005
513source: national psoriasis foundation march 2005 Researchers at the Universitysoftware salesperson-3/7/2005
512source: national psoriasis foundation march 2005 updated table.i can't figusoftware salesperson-3/7/2005
511New Phase II Data Shows Improvement in Disease Activity and Quality of Life for nigel bates-2/18/2005
510Multiple Course Efficacy and Safety Results of AMEVIVE-R- -Alefacept- in Psoriasscaram(o)uche-2/18/2005
509Low dose methotrexate vasculoprotective in psoriasis patients. NEW YORK Mon Febnigel bates-2/15/2005
508Large review article <i>PSORIASIS: EMERGING THERAPEUTIC STRATEGIES</i&ghmpa-1/7/2005
507GPC / Debiopharm / Small Molecule MHC Class II Antagonists Program for Autoimmunnigel bates-12/17/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News